Tuesday, November 24, 2020 8:47:56 AM
As the 2021 Annual Meeting will be held more than 30 days prior to the first anniversary of the Company's 2020 annual meeting of shareholders, which was held on March 11, 2020, shareholders of the Company who wish to have a proposal considered for inclusion in the Company's proxy materials for the 2021 Annual Meeting must provide written notice that is received by the Company's Secretary at the Company's corporate headquarters, 1415 Louisiana, Suite 3500, Houston, Texas 77002, on or before the close of business on December 1, 2020, which the Company has determined to be a reasonable time before it expects to begin to print and send its proxy materials.
Any such shareholder proposal must be submitted and must comply with the applicable rules and regulations of the Securities and Exchange Commission, including Rule 14a-8 of the Securities Exchange Act of 1934, as amended (as applicable), Nevada law and the Company's Amended and Restated Bylaws.
Additional Information and Where to Find It
As noted above, in connection with the Annual Meeting, the Company will file with the Securities and Exchange Commission (the "SEC") a proxy statement and other relevant documents. It is anticipated that a Notice of Internet Availability of Proxy Materials ("Notice") relating to the Annual Meeting will be sent to each shareholder registered in the share register of the Company as of the close of business on the record date (provided the Company may alternatively, in its discretion, send each shareholder a form of the proxy and the Company's latest annual report). Instructions on how to access the proxy materials over the Internet or request a printed set of proxy materials will be provided in the Notice. The Notice (or proxy, if the proxy is mailed) also will provide instructions on how to submit a proxy over the Internet or via mail.
Recent CEI News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:30:23 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:01:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:59:42 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/15/2023 09:16:32 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/18/2023 09:15:30 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/18/2023 09:15:17 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/26/2023 09:02:52 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/07/2023 12:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2023 08:09:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 01:00:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 12:02:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 12:40:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:38:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 12:44:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM